A panel of advisers to FDA gave its endorsement to a seasonal mRNA flu vaccine that was developed by Moderna and that earlier this year became the subject of controversy.
@lizzylawrence.bsky.social reporting in @statnews.com a critical piece of this story: Director Prasad overruling career staff to not even allow Moderna to apply for review of their mRNA-based influenza vaccine.
This is harmful for multiple reasons...
@drsforamerica.bsky.social
The rejection is the latest instance of Vinay Prasad overruling career FDA scientists to place vaccines under harsher scrutiny.